12 Oral Tongue Cancer

Table 9.1 Results for treatment of mobile-tongue cancer

Authors Akine [1] Benk [2] Bolla [3]

N Pts TNM - Stage

Treatment BT, Cryo, S A 85, B 25 A 312, B 148, C 67, D 69 A 127, B 80 A 194, B 75 B

Brachy Survival %

Local control %

Complications %

224 110 218 602 207 269

I, II

LDR LDR LDR LDR LDR LDR

72

BT 90, Cryo 89, S 84

II

DFS: A42, B 24

A 88, B 36

I II 35, III 5

T1, T2 T3

T1 66, T2 51,T3 27 T1 80, T2 56, T3 25

T1 62, T2 53,T3 30

Decroix [5]

T1 96, T2 289, T3 217

76

STN 24 ORN 13

Fujita 6]

T1 93, T2 114

T1 83, T2 69 T1 T2 T3 A 62, B 30

T1 93, T2 77 T1 T2 T3 A 87, B 49 T1-2 92, T3 71

11

Gerbaulet [7] Haie [9]

T1 83, T2 148, T3 38

STN 11 ORN 13 STN 20 ORN 13

Hareyama [10] 130

T1, T2, T3

A 99, B 31

Inoue [11]

29

T1, T2, T3

LDR/HDR

15/14

86/100

Lefebvre [14]

283

T1 81, T2 170, T3 32

A A A

LDR LDR LDR LDR LDR

T1 87, T2 84, T3 62

Mahe [15]

24

92

STN 16

T1 T2 ≤ 3, N0

Mazeron [17]

166

T1 N0 70, T2 N0 83, T1-T2 N1-N2 13

T1 N0 52, T2 N0 44, T1-T2 N1-N2 8

T1 N0 87, T2 N0 92, T1-T2 N1-N2 69

Pernot [24] Pernot 25]

147 448

T2 N0

A 70, B 77 A 181B 267

A 62, B 35

A 90, B 51

T1 125, T2 186, T3 123, T4 4

T1 69, T2 41, T3 25

T1 93, T2 65, T3 49

Shibuya [28]

370

I 90, II 280

A, B

I 84, II 75

Spf 85, exoph 79, infiltr 45 A 65 C 28 B1 92 B2 69

Gr2 38, Gr3 4

Wendt [30]

103

T1, T2, T3

A 18 C 8 B1 RT <40Gy 31 B2 RT >40 Gy 46

LDR

A 89, C57 B1 78 B2

ORN A 0 C 0 B1 4 B2 17

Legends: ƒ Treatments: A: Brachytherapy (BT) ƒ Complications: STN: soft tissue necrosis ƒ Aspects of Tumour: spf: superficial

B: EBRT + brachytherapy (BT) ORN: osteoradionecrosis

C: EBRT

D: surgery (S) + radiotherapy (RT)

exoph: exophytic

infiltr: infiltrating